Bayer Aktiengesellschaft (BAYRY) Stock Analysis
A live, multi-source view of Bayer Aktiengesellschaft (BAYRY): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing.
Sector: Healthcare · Industry: Drug Manufacturers - General · Germany · 87,830 employees · bayer.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Bayer Aktiengesellschaft (BAYRY) had a market capitalization of $55.76B (forward 10.3), a dividend yield of 0.23% and a beta of 0.83; the shares traded in a 52-week range of $7.48 – $15.23 (73.1% over the year).
- Market cap
- $55.76B
- Enterprise value
- $89.24B
- Forward P/E
- 10.3
- PEG ratio
- 4.61
- Price / book
- 1.63
- EPS (trailing)
- $-0.51
- EPS (forward)
- $1.37
- Dividend yield
- 0.23%
- Payout ratio
- 161.5%
- Ex-dividend date
- 2026-04-28
- 52-week range
- $7.48 – $15.23
- 52-week change
- 73.1%
- Beta
- 0.83
- Average volume
- 827,398
- Shares outstanding
- 3.93B
- Profit margin
- -3.8%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-08
In RapidTradeView’s 2026-09-08 scan of the US universe, Bayer Aktiengesellschaft (BAYRY) last closed at $14.19 (the last completed close before that scan).
Technicals at the scan: RSI 54 (neutral territory), price +0.4% versus its 20-day average, 20-day versus 50-day average spread +1.1%, MACD histogram -0.03.
Sentiment inputs: 100% of recent Finnhub-scored headlines read bullish; StockTwits 100% bullish; analyst consensus score 69/100.
Next scheduled company event: in 56 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
RapidTradeView has recorded no Congress or insider filing for BAYRY in the last 90 days. Coverage of House, Senate and SEC Form 4 filings began in July 2026, and insider sells are tracked for universe tickers only, so this is our record, not a guarantee that nothing was filed. Who is trading what
RapidTradeView pick record
BAYRY has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Bayer Aktiengesellschaft (BAYRY) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell BAYRY.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.